Advertisement
 
 
Log in
Welcome Guest



User:
Pass:
Anonymous: 
Advertisement
Donate To Depression Forums
Latest Forum Discussions
on: Friday, 08 August 2008 15:06
on: Friday, 08 August 2008 13:52
on: Friday, 08 August 2008 13:46
on: Friday, 08 August 2008 13:13
on: Friday, 08 August 2008 12:57
Search

Advanced Search

Member Testimonials
QUOTE (Dr_Bunsen_Honeydew @ Jul 6 2008, 12:56 PM) * Hello. I'm a new member to this site but have been 'researching' here for quite awhile. I just want to say I'm happy i found this website. Like everyone else here I'm looking for answers. I decided to join because maybe some of my experiences can help other people in the same way i was helped by so many posters. Just think it's a great community and really look forward to being a part of it! Thanks
(Dr_Bunsen_Honeydew)
HOPELINE 1-800-SUICIDE
hopeline.com
Depression & Mental Health FAQs
US Centers for Disease Control and Prevention (CDC) estimated 40 million
Americans living today will suffer from major depressive illness during their lives.

Seasonal affective disorder is major depression that appears in the fall or winter and goes away in spring, thought to be caused by lack of sunlight.



Postpartum depression occurs within four weeks of a women giving childbirth. Most new mothers suffer from some form of the �baby blues.� Postpartum depression, by contrast, is major depression, thought to be triggered by changes in hormonal flows associated with childbirth.

Catatonic depression is a rare form of major depression characterized by (at least two): Stupor, excessive motor activity, extreme negativism, peculiarities in voluntary movement, and repetition of other people's words or actions. - mcmanweb.com



Psychotic depression is a rare form of depression characterized by delusions or hallucinations, such as believing you are someone you are not and hearing voices.


According to the National Institute of Mental Health, approximately 18.8 million American adults, or about 9.5 percent of the US population age 18 and older in a given year, have a depressive disorder.
Depression is a chronic illness that exacts a significant toll on America's health and productivity.  It affects more than 21 million American children and adults annually and is the leading cause of disability in the United States for individuals ages 15 to 44.


Lost productive time among U.S. workers due to depression is estimated to be in excess of $31 billion per year.  Depression frequently co-occurs with a variety of medical illnesses such as heart disease, cancer, and chronic pain and is associated with poorer health status and prognosis.  It is also the principal cause of the 30,000 suicides in the U.S. each year.  In 2004, suicide was the 11th leading cause of death in the United States, third among individuals 15-24.


According to the World Health Organization, depression is presently on track to becoming the world's second-most disabling disease (after heart disease) by the year 2020.

Depression is responsible for some $87 billion a year in lost productivity in the US (a conservative estimate), and according to Bank One, is responsible for most lost work days in its employees after pregnancy and childbirth.

Additionally, one million people worldwide die by their own hand, most as a result of a mood disorder. Finally, the linkage between depression and a host of physical illnesses makes it arguably the world's greatest killer.

Research presented at the 56th Annual Conference of the Canadian Psychiatric Association shows a marked link between bipolar disorder and migraines.

The odds of migraine in persons with bipolar disorder were 40% higher than the general population.

Data obtained from 36,984 people aged 15 and over, who screened positive for manic or depressive episodes with migraine, were compared against those who screened positive for mania but who didn�t suffer from migraines.

Amongst males, 14.9% of those with manic episodes were also diagnosed with migraines compared with 5.8% of the general population. Amongst females, 34.7% had both migraines and bipolar disorder compared with 14.7% who only had migraines.unquote.gif

While the research was skewed towards persons who were already diagnosed with bipolar disorders, what does it mean for people who suffer from migraines but who may have an undiagnosed bipolar disorder?



Migraines and headaches aren�t fully understood but the manifestations are very real and debilitating for their sufferers:

Throbbing pain
Nausea
Heightened sensitivity to light or sound
Seeing dots, wavy lines, flashing lights, or blind spots
Difficulty with speech, sensation, or movement

 


An estimated 2.1 million American adolescents have experienced major depression within the last year, according to a new comprehensive government study.  Researchers surveyed more than 67,000 young people ages 12 to 17 and found that one in 12 had suffered from serious depression in the previous year.Nearly 13 percent of girls had struggled with depression, compared to less than 5 percent of boys. Odds of depression increased with age -- just 4 percent of 12-year-olds experienced depression but that climbed to 11 percent for older teens.

Our DF Members
www.flickr.com
This is a Flickr badge showing photos in a set called DF Potpourii. Make your own badge here.

All Depressed Brains Are Not the Same

By kstours

From Nancy Schimelpfening

All Depressed Brains Are Not the Same

Very often I am asked to recommend a good antidepressant. My answer, other than the obvious, "Please see your doctor for medical advice", is this: "the one that works for you"!

Each class of antidepressant works on your brain chemistry in a different way. Dr. Abbott Lee Granoff, a noted expert in the field of panic disorder and depression, says the following: "There are currently 23 antidepressants on the market (Guide Note: this figure is for the US only. There are some antidepressants available in other countries which are not approved for use in the US). Each increases certain neurotransmitters in the brain and each can do this in slightly different parts of the brain."1 So, while one person may get relief from having their serotonin boosted, another may need a drug that affects both serotonin and norepinephrine. Still another person may need an entirely different sort of medication, such an anticonvulsant or a mood stabilizer like lithium. Further, a person who does well on a medication such as Zoloft may not do as well on Prozac, even though both belong to the same class.2 Each person will be very different in their medication needs.

Just like the wide variety of brains, there are a wide variety of antidepressants. Broadly speaking, these fall into the following classes: monoamine oxidase inhibitors (MAOIs), tricyclics (TCAs) and selective serotonin reuptake inhibitors (SSRIs). There are also several newer medications that are unique in their mechanism of action.

Monoamine Oxidase Inhibitors

The monoamine oxidase inhibitors (MAOIs) were some of the first antidepressant medications developed. The neurotransmitters responsible for mood, primarily norepinephrine and serotonin, are also known as monoamines. Monoamine oxidase is an enzyme which breaks these substances down. Monoamine oxidase inhibitors, as the name implies, inhibits this enzyme, thus allowing a greater supply of these chemicals to remain available.

MAOIs have fallen out of favor as first-line antidepressants because they offer several disadvantages to patients compared to newer medications. Potentially fatal drug-drug interactions can occur with MAOIs when combined with a variety of drugs which are serotonin agonists (the "serotonin syndrome") or norepinephrine agonists.3 People on these medications must also follow strict dietary restrictions of foods rich in tyramine4 to avoid potential hypertensive (high blood pressure) crisis. A major adverse effect that occurs on MAOIs alone is hypotension (low blood pressure), which can present as fatigue and may mimic worsening of the underlying depressive syndrome. For this reason, the blood pressure should always be monitored when using these antidepressants.5

Tricyclics

Tricyclics, also known as heterocyclics, came into broad use in the 1950's. These drugs inhibit the nerve cell's ability to reuptake serotonin and norepinephrine, thus allowing a greater amount of these two substances to be available for use by nerve cells.

In addition to acting on norepinephrine and serotonin, tricyclics exhibit similar effects on histamine and acetylcholine. This is responsible for the troublesome side-effects we usually associate with these medications, such as dry mouth, blurry vision, weight gain and sedation.6

With tricyclics, a patient's medical history must be closely considered. These medications may cause orthostatic hypotension (dizziness upon standing); rapid heartbeat, sometimes with palpitations; and may aggravate preexisting heart conditions. Patients with a history of seizures or head injury must also be cautious as these drugs may cause seizure.7

Selective Serotonin Reuptake Inhibitors

Claims of decreased side-effects and increased safety relative to the older medications have made this class of antidepressant very popular in recent years. Five drugs currently belong to this class: fluoxetine (Prozac), citalopram (Celexa), fluvoxamine (Luvox), sertraline (Zoloft), and paroxetine (Paxil).

SSRI stands for Selective Serotonin Reuptake Inhibitor. These medications work, as the name implies, by blocking the presynaptic serotonin transporter receptor.8 This drug differs from the tricyclics in that it's action is specific to serotonin only. It's effect on norepinephrine is indirect, through the fact that falling serotonin "permits" norepinephrine to fall so preserving serotonin preserves norepinephrine.9

SSRIs, through their specificity, have the advantage of not affecting histamine and acetylcholine. The implication is that although they are not without side-effects, they do not create the same bothersome side-effects as the tricyclics.

Newer Mechanisms

Five newer medications which do not fit into the above categories are: buproprion (Wellbutrin), nefazodone (Serzone), trazodone (Desyrel), venlafaxine (Effexor), and mirtazapine (Remeron).

The mechanism of bupropion's antidepressant activity is poorly understood, but is thought to be mediated through noradrenergic or dopaminergic pathways or both.10 This medication lacks the sexual side-effects so common to the SSRIs and is popular for patients who exhibit a lack of energy, psychomotor slowness and excessive sleep.

Nefazodone and it's precursor trazodone both inhibit neuronal reuptake of serotonin and, to a lesser extent, norepinepherine. They also blocks postsynaptic 5-HT2 receptors. Nefazodone has weak affinity for cholinergic and a1- adrenergic receptors and, therefore, is associated with less sedation and orthostasis than trazodone.11

Venlafaxine is a compound that is structurally unrelated to other antidepressants.12 Like the TCAs, venlafaxine inhibits the neuronal uptake of both serotonin and norepinepherine. Venlafaxine has dose-dependent, sequential effects on the uptake pumps for serotonin and then norepinephrine.. At 75 mg/day, venlafaxine is predominantly a serotonin reuptake inhibitor (SRI) like the SSRIs. At 375 mg/day, it produces comparable norepinephrine uptake inhibition to an NSRI such as desipramine.13

Mirtazapine is the most recently released of these four and is the first a2-antagonist marketed as an antidepressant.14 Mirtazapine's unique mechanism of action does not involve enzyme inhibition or blockade of neurotransmitter reuptake. Mirtazapine increases the release of norepinepherine from central noradrenergic neurons by blocking the presynaptic inhibitory alpha-2 autoreceptors. It spares the alpha-1 postsynaptic receptor and therefore results in net increase noradrenergic transmission. As a second presynaptic receptor blocking function, mirtazapine blocks the inhibitory alpha-2 heteroreceptors located on serotonergic neurons, resulting in increase release of serotonin. Postsynaptically, mirtazapine has low affinity for the 5-HT1A receptor, thus allowing serotonin released into the synapse to bind to and stimulate this receptor. However, it blocks postsynaptic 5-HT2 and 5-HT3 receptors. Stimulation of the 5-HT2 receptor is thought to be responsible for the serotonergic side effects of insomnia, agitation, and sexual dysfunction seen with the SSRI's and 5-HT3 receptor stimulation is thought to mediate nausea seen with these agents.15, 16, 17 Therefore, mirtazapine's receptor blocking profile prevents the side-effects seen with nonselective activation of serotonin receptors which occurs with pure reuptake blockers.

Source: About.com

Comments

This Month In Pictures
Members Online
91 Users Online:
82  Guests
0  Anonymous
9  Visible:
chel, Dante 2599, above_and_beyond, Grantith, Forum Admin, zen again, Always Trying, QNA, pinknixon,
Medical News
Depression News From Medical News Today
Latest Depression News From Medical News Today.

Likely Cause Of Postpartum Blues And Depression Identified
Unique biochemical crosstalk that enables a fetus to get nutrition and oxygen from its mother's blood just may cause common postpartum blues, researchers say. That crosstalk allows the mother's blood to flow out of the uterine artery and get just a single cell layer away from the fetus' blood, says Dr. Puttur D. Prasad, biochemist in the Medical College of Georgia School of Medicine.

Research Helps Patients Find Antidepressants That Work
In spite of the range of medications now available, major depression remains a challenging disease to treat. Only about half of adult patients respond to the first antidepressant they try, with only one-third achieving remission, reports the August 2008 issue of the Harvard Mental Health Letter. Most adults will try two or more medications before finding one that alleviates their depression.




ADHD News From Medical News Today
Latest ADHD News From Medical News Today.

Shire Re-Launches ADHDSupport.com, A Virtual Road Map Providing Information, Tools And Practical Tips About Attention Deficit Hyperactivity Disorder
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today the re-launch of its educational Web site, ADHDSupport.com, designed to provide families, caregivers, educators and patients with tools and resources about Attention Deficit Hyperactivity Disorder (ADHD). The newly enhanced ADHDSupport.

Celebrity Designer And ADHD Spokesperson Ty Pennington Partners With Shire To Announce The Launch Of VYVANSE™ For Adult ADHD Treatment
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has launched VYVANSE™ (lisdexamfetamine dimesylate) for the treatment of adults with Attention Deficit Hyperactivity Disorder (ADHD). This launch follows the recent FDA approval of VYVANSE to treat ADHD in the adult population. VYVANSE is now available in U.S. pharmacies nationwide in six once-daily dosage strengths.




Anxiety / Stress News From Medical News Today
Latest Anxiety / Stress News From Medical News Today.

Back To School: More Stressful Than Parents Think
August can be a stressful time for teens and tweens, as they prepare to face another school year - and with it, new social and academic pressures. The Partnership for a Drug-Free America recently released a survey showing that the number one reason for teenage drug and alcohol abuse is to deal with school-related pressures.

Study Indicates Higher Incidence Of Childbirth-Related PTSD Than Previously Thought
Nearly one in 10 U.S. women who have given birth recently meet the formal criteria for post-traumatic stress disorder resulting from childbirth, according to a survey released this week by the not-for-profit maternity care group Childbirth Connection, the




Bipolar News From Medical News Today
Latest Bipolar News From Medical News Today.

FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.

Depression And Bipolar Results Worth Striving For - A New Recovery Model For Mental Illness
Bipolar Advantage Inc. will be introducing a new integrated recovery program called the "Advantage Program" on September 6, 2008. "The days of thinking a diagnosis of bipolar disorder means living a diminished life are over," says company president Tom Wootton.




Mental Health News From Medical News Today
Latest Mental Health News From Medical News Today.

Struggles Of Adolescence Can Be Particularly Painful For Children Who Also Struggle With Obesity
New research suggests that traits such as obesity during adolescence that may increase the risk of attacks from peers can result in health and psychological struggles that remain through young adulthood. The researchers say that this is one of the first studies to explore a possible link between victimization and weight changes for obese adolescents.

Fewer Psychiatrists Providing Psychotherapy
Fewer office-based psychiatrists are personally offering psychotherapy to their patients according to an article released on August 4, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. The intervention of psychotherapy has been a strong part of the practice of psychiatry since its inception. Usually involving verbal communication, it is used to help patients live to a higher potential independently or in addition to medication.




Psychology / Psychiatry News From Medical News Today
Latest Psychology / Psychiatry News From Medical News Today.

Likely Cause Of Postpartum Blues And Depression Identified
Unique biochemical crosstalk that enables a fetus to get nutrition and oxygen from its mother's blood just may cause common postpartum blues, researchers say. That crosstalk allows the mother's blood to flow out of the uterine artery and get just a single cell layer away from the fetus' blood, says Dr. Puttur D. Prasad, biochemist in the Medical College of Georgia School of Medicine.

Gender Stereotypes Contradicted When Negotiating
A common gender stereotype assumes that men are more aggressive and women are more emotional. In negotiation, men are assumed to be more assertive and women better at fostering relationships. However, a new study published in Negotiation and Conflict Management Research reveals that when people are trying to make a positive impression, they may behave in ways that contradict gender stereotypes.




Schizophrenia News From Medical News Today
Latest Schizophrenia News From Medical News Today.

Human Brains Pay A Price For Being Big
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.

Psychotic Symptoms Relieved With Estrogen Treatment
The estrogen estradiol, in combination with antipsychotic medications, appears to improve treatment for women with schizophrenia, according to an article releasedon August 4, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. Previously, mental illness has been studied in conjunction with many different hormones, especially estrogen in women. However, the use of estrogen as a therapy for these diseases has only gained focus recently.




Sleep / Sleep Disorders / Insomnia News From Medical News Today
Latest Sleep / Sleep Disorders / Insomnia News From Medical News Today.

Young People Who Sleep Less Have More Risk Of Being Overweight
Young people who sleep less may be more likely to be overweight, especially if they spend less time in rapid eye movement (REM) sleep, according to a report released on August 4, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. The obesity epidemic in the United States is well recognized, and has been occurring even in children.

Worms Help Us Uncover Key Insights Into Origing Of Depression, Insomnia And Memory
Researchers have spent decades probing the causes of depression, schizophrenia and insomnia in humans. But a new study in this week's PLoS Biology may have uncovered key insights into the origins of these and other conditions by examining a most unlikely research subject: worms. The project, which was led by Oklahoma Medical Research Foundation scientist Kenneth Miller, Ph.D., examined the way eye-less microscopic worms known as C.




Andertoon
Vote for DF
Rate this Site for Psych Central:
A Potpourri of Mental Health Articles
Mental Health Parity News
Suicide Prevention Llifeline
suicidepreventionlifeline.org
Amazon Books
Advertisement

Pass Through PanicPass Through Panic

Claire Weekes

New $15.61

SOS Help for EmotionsSOS Help for Emotions

Lynn Clark

New $11.20

The Instinct to HealThe Instinct to Heal

David Servan-Schre...

New $10.85

Anxiety & Depression Wor...Anxiety & Depression Workbook For Du...

Charles H., PhD El...

New $13.59

Depressed and AnxiousDepressed and Anxious

Thomas Marra

New $14.93

Depression-Free, Natural...Depression-Free, Naturally

Joan Mathews Larso...

New $10.17
Our Soldiers & Veterans
edclogo


eatingdisorderscoalition.org
Depression & Mental Health FAQs 2
What is Clinical Depression?

Clinical depression can affect your body, mood, thoughts, and behavior. It can change your eating habits, how you feel and think about things, your ability to work and study, and how you interact with people.

Clinical depression is not a passing mood, a sign of personal weakness or a condition that can be willed away. Clinically depressed people cannot "pull themselves together" and get better.

Depression can be successfully treated by a mental health professional or certain health care providers. With the right treatment, 80 percent of those who seek help get better. And many people begin to feel better in just a few weeks.

Depression a Big Factor in Poor Health
World Health Organization Finds Depression Often Goes Untreated
By Salynn Boyles
WebMD Medical News
Reviewed by Louise Chang, MD

Sept. 6, 2007 -- Depression has a greater impact on overall health than arthritis, diabetes, angina, and asthma, but it all too often goes unrecognized and untreated, a report from the World Health Organization (WHO) suggests.
more...Depression a Big Factor in Poor Health

For Additional Information About Depression Write To:
The National Institute of Mental Health (NIMH)
6001 Executive Boulevard, Room 8184, MSC 9663
Bethesda, MD 20892-9663
 

For free brochures on depression and its treatment call:  1-800-421-4211.
or visit: http://www.nimh.nih.gov
Link To Us
Please use the image below and the code provided to link back to us




Advertisement